EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Design, Synthesis, In Vitro and In Vivo Evaluation of Novel Anti-Alzheimer’s (1E,4E)-1,5-Bis[(het)aryl]penta-1,4-dien-3-one Derivatives

Géssica Oliveira Mendes iD, Lucas Diego Pereira Bento, Thiago Malverde de Oliveira iD, Deyse Brito Barbosa iD, Guilherme Saraiva Tsui, Ellen Nunes Gomes, Raphaela Oliveira Sales, Mateus Silva de Castro Rocha, Michel Pires da Silva iD, Tiago Alves de Oliveira iD, Eduardo Habib Bechelane Maia, Daniel Luciano Falkoski and 12 more

Pharmaceuticals · 2026-08-01 · 19 (8) · 1216

DOI: 10.3390/ph19081216 ↗

At a glance

Journal article in Pharmaceuticals, published online on 2026-08-01. Written by Géssica Oliveira Mendes and 23 co-authors. Institution: Graduate Program in Biotechnology, State University of Feira de Santana, Feira de Santana 44036-900, BA, Brazil. 81 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, National Council for Scientific and Technological Development, Minas Gerais State Research Support Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background/Objectives: Alzheimer’s disease (AD) is a progressive, multifactorial neurodegenerative condition characterized by neurofibrillary tangles, neuronal loss, cognitive impairment, and accumulation of β-amyloid plaques. Considering the limitations of current treatments, which present adverse effects and only alleviate symptoms without modifying disease progression, there is an urgent need for new therapeutic approaches. This study aimed to investigate the neuroprotective potential of synthetic derivatives of (1E,4E)-1,5-bis[(het)aryl]penta-1,4-dien-3-ones, focusing on the inhibition of the cholinesterase enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), targets directly related to the cholinergic deficit observed in AD.

Methods

The compounds were initially synthesized by aldol condensation reactions, with subsequent physicochemical characterization. They were then subjected to in silico assays that demonstrated high binding affinity to the active sites of AChE and BChE. The derivatives were evaluated in vitro for their inhibitory activity on these enzymes and in vivo in an experimental model of AD induced by streptozotocin in Wistar rats.

Results

The synthesized derivatives showed favorable predicted interactions with the active sites of AChE and BChE, supporting their potential as cholinesterase inhibitors. In vitro assays demonstrated inhibitory activity against both enzymes, with selected derivatives showing improved activity compared with the parent scaffold. In the in vivo model, treatment with the selected compounds was associated with neuroprotective effects, suggesting preservation of nervous tissue integrity under AD-like conditions.

Conclusions

These findings indicate that derivatives may represent promising candidates for further investigation as multitarget agents for AD. The study reinforces the relevance of integrating organic synthesis, molecular modeling, enzymatic assays, and in vivo evaluation in the search for new therapeutic strategies for neurodegenerative diseases.

Subjects

Author keywords

Alzheimer’s diseaseassaysin silicoin vitroin vivomultitarget drugs

Authors and institutions

  • Graduate Program in Biotechnology, State University of Feira de Santana, Feira de Santana 44036-900, BA, Brazil.
  • Laboratory of Cheminformatics and Biological Evaluation, Department of Health, State University of Feira de Santana, Feira de Santana 44036-900, BA, Brazil.
  • Department of Natural Sciences, Federal University of São João del-Rei, São João del-Rei 36301-160, MG, Brazil.
  • Department of Medicine, Federal University of São João del-Rei, Praça Dom Helvécio, 74, Dom Bosco, Minas Gerais, São João del-Rei 36301-160, MG, Brazil.
  • Department of Computer Science, Federal Center of Technological Education of Minas Gerais, Álvares de Azevedo 400, Bela Vista, Minas Gerais, Divinópolis 35503-822, MG, Brazil.
  • Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-100, BA, Brazil.

ORCID profiles: Géssica Oliveira Mendes, Thiago Malverde de Oliveira, Deyse Brito Barbosa, Michel Pires da Silva, Tiago Alves de Oliveira, Lucas Matheus Gonçalves de Oliveira, Victor Diogenes Amaral da Silva, Paulo Batista de Carvalho, Alisson Marques da Silva, Laila Cristina Moreira Damázio, Franco Henrique Andrade Leite

Funding

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • National Council for Scientific and Technological Development
  • Minas Gerais State Research Support Foundation
  • Deep Tech
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Cite

APA

Mendes, G. O., Bento, L. D. P., Oliveira, T. M., Barbosa, D. B., Tsui, G. S., Gomes, E. N., Sales, R. O., Rocha, M. S. C., Silva, M. P. D., Oliveira, T. A., Maia, E. H. B., Falkoski, D. L., Marra, I. F. S., Andrade, L. S. M., Mendes, L. C. V. P., Fonseca, B. S., Oliveira, L. M. G., Silva, V. D. A. D., Carvalho, P. B., …, & Leite, F. H. A. (2026). Design, Synthesis, In Vitro and In Vivo Evaluation of Novel Anti-Alzheimer’s (1E,4E)-1,5-Bis[(het)aryl]penta-1,4-dien-3-one Derivatives. Pharmaceuticals, 19(8), 1216. https://doi.org/10.3390/ph19081216

Vancouver

Mendes GO, Bento LDP, Oliveira TM, Barbosa DB, Tsui GS, Gomes EN, et al. Design, Synthesis, In Vitro and In Vivo Evaluation of Novel Anti-Alzheimer’s (1E,4E)-1,5-Bis[(het)aryl]penta-1,4-dien-3-one Derivatives. Pharmaceuticals. 2026;19(8):1216. doi:10.3390/ph19081216

BibTeX
@article{Mendes2026,
  author = {Mendes, Géssica Oliveira and Bento, Lucas Diego Pereira and Oliveira, Thiago Malverde de and Barbosa, Deyse Brito and Tsui, Guilherme Saraiva and Gomes, Ellen Nunes and Sales, Raphaela Oliveira and Rocha, Mateus Silva de Castro and Silva, Michel Pires da and Oliveira, Tiago Alves de and Maia, Eduardo Habib Bechelane and Falkoski, Daniel Luciano and Marra, Isabella Flores de Souza and Andrade, Lorena Silva Matos and Mendes, Liliane Costa Vanessa Pereira and Fonseca, Bianca de Souza and Oliveira, Lucas Matheus Gonçalves de and Silva, Victor Diogenes Amaral da and Carvalho, Paulo Batista de and Silva, Alisson Marques da and Taranto, Alex Gutterres and Damázio, Laila Cristina Moreira and Valle, Marcelo Siqueira and Leite, Franco Henrique Andrade},
  title = {Design, Synthesis, In Vitro and In Vivo Evaluation of Novel Anti-Alzheimer’s (1E,4E)-1,5-Bis[(het)aryl]penta-1,4-dien-3-one Derivatives},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {1216},
  doi = {10.3390/ph19081216}
}
Start for free →